西妥昔单抗诱发的头颈癌患者肺炎 - Suppr

Suppr

超能文献

Cetuximab-induced pneumonitis in head and neck cancer patient.

作者信息

De Vos F Y F L, Driessen C M L, Jaspers H C J, van Herpen C M L, Simons B

出版信息

Oral Oncol. 2012 Jun;48(6):e17-8. doi: 10.1016/j.oraloncology.2012.01.023. Epub 2012 Feb 17.

DOI:10.1016/j.oraloncology.2012.01.023

PMID:22342570

Abstract

摘要

相似文献

Cetuximab-induced pneumonitis in head and neck cancer patient.

Oral Oncol. 2012 Jun;48(6):e17-8. doi: 10.1016/j.oraloncology.2012.01.023. Epub 2012 Feb 17.

Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.

Clin Oncol (R Coll Radiol). 2008 Nov;20(9):717. doi: 10.1016/j.clon.2008.07.003. Epub 2008 Aug 30.

Rash conclusions from a phase 3 study of cetuximab?

Lancet Oncol. 2010 Jan;11(1):2-3. doi: 10.1016/S1470-2045(09)70348-1.

Acneiform rash secondary to cetuximab plus head and neck radiotherapy.

Radiother Oncol. 2007 Oct;85(1):171. doi: 10.1016/j.radonc.2007.04.034. Epub 2007 May 24.

Cetuximab and radiotherapy for head and neck cancer.

N Engl J Med. 2006 Feb 9;354(6):634-6. doi: 10.1056/NEJMe058306.

Cetuximab plus radiotherapy for head and neck cancer.

N Engl J Med. 2006 May 18;354(20):2187; author reply 2187.

Cetuximab plus radiotherapy for head and neck cancer.

N Engl J Med. 2006 May 18;354(20):2187; author reply 2187.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10.

More on cetuximab in head and neck cancer.

N Engl J Med. 2007 Nov 22;357(21):2201-2; author reply 2202-3. doi: 10.1056/NEJMc071540.

Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

N Engl J Med. 2007 Aug 2;357(5):514-5. doi: 10.1056/NEJMc071075.

引用本文的文献

Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis.

Mol Clin Oncol. 2016 Aug;5(2):246-252. doi: 10.3892/mco.2016.928. Epub 2016 Jun 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cetuximab-induced pneumonitis in head and neck cancer patient.

Oral Oncol. 2012 Jun;48(6):e17-8. doi: 10.1016/j.oraloncology.2012.01.023. Epub 2012 Feb 17.

Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.

Clin Oncol (R Coll Radiol). 2008 Nov;20(9):717. doi: 10.1016/j.clon.2008.07.003. Epub 2008 Aug 30.

Rash conclusions from a phase 3 study of cetuximab?

Lancet Oncol. 2010 Jan;11(1):2-3. doi: 10.1016/S1470-2045(09)70348-1.

Acneiform rash secondary to cetuximab plus head and neck radiotherapy.

Radiother Oncol. 2007 Oct;85(1):171. doi: 10.1016/j.radonc.2007.04.034. Epub 2007 May 24.

Cetuximab and radiotherapy for head and neck cancer.

N Engl J Med. 2006 Feb 9;354(6):634-6. doi: 10.1056/NEJMe058306.

Cetuximab plus radiotherapy for head and neck cancer.

N Engl J Med. 2006 May 18;354(20):2187; author reply 2187.

Cetuximab plus radiotherapy for head and neck cancer.

N Engl J Med. 2006 May 18;354(20):2187; author reply 2187.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10.

More on cetuximab in head and neck cancer.

N Engl J Med. 2007 Nov 22;357(21):2201-2; author reply 2202-3. doi: 10.1056/NEJMc071540.

Severe cutaneous reaction during radiation therapy with concurrent cetuximab.

N Engl J Med. 2007 Aug 2;357(5):514-5. doi: 10.1056/NEJMc071075.

引用本文的文献

Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis.

Mol Clin Oncol. 2016 Aug;5(2):246-252. doi: 10.3892/mco.2016.928. Epub 2016 Jun 13.